Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Recombinant Chemicals Market to reach USD 5.70 billion by 2032

Global Recombinant Chemicals Market Size Study, by Product Type (Recombinant Proteins, Recombinant DNAs, Recombinant Peptides, Others), by Technology (Microbial Expression Systems, Mammalian Cell Expression Systems, Yeast Expression Systems, Insect Cell Expression Systems, Cell-free Expression Systems), by Application (Drug Development, Vaccine Production, Therapeutics, Cell Line Development, Agriculture, Food and Beverage, Others), and Regional Forecasts 2022-2032

Product Code: HLSB-79850794
Publish Date: 25-08-2024
Page: 200

The Global Recombinant Chemicals Market is valued at approximately USD 2.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.8% over the forecast period 2024-2032. Recombinant chemicals, produced through genetic engineering techniques, include recombinant proteins, DNAs, and peptides. Recombinant proteins are polypeptides produced from cloned genes and are widely employed in fields such as medicine, research, and biotechnology due to their advantages such as high purity, specificity, efficiency, safety, customization, scalability, and consistency. Recombinant proteins are used in vaccine development, therapeutics, diagnostics, and drug discovery and development. They include cytokines, enzymes, hormones, blood clotting factors, growth factors, monoclonal antibodies (mAbs), and antibody-related products. Recombinant protein vaccines are considered safer than vaccines derived from live viruses as they are non-replicating and lack infectious components.

The rise in demand for recombinant protein vaccines is significantly driving the market value of recombinant chemicals. Recombinant protein vaccines, which constitute a proven and well-established vaccine development platform, are particularly in demand due to the increased need for recombinant protein-based SARS-CoV-2 vaccines, thereby augmenting the demand for DNA-derived chemicals. The prevalence of genetic disorders is also fueling the recombinant chemicals market development. Medicinal products produced through recombinant DNA technology have revolutionized the treatment and management of various genetic disorders. Key players operating in the recombinant chemicals market are producing high-purity recombinant products for studying antibody and enzyme binding sites, as well as novel small therapeutics, drug agents, and vaccines.

Recombinant DNA technology, which involves the joining of DNA molecules from two different species, is gaining traction in the production of pharmaceutical and biotechnological products, including nutraceuticals. Products such as Elelyso, which contains the active substance taliglucerase alfa, are produced using recombinant DNA technology for the treatment of genetic disorders like type 1 Gaucher disease.

Key regions considered for the global Recombinant Chemicals Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. In 2023, North America stands out as the dominating region. This dominance is primarily driven by the presence of advanced biotechnology infrastructure, significant investments in research and development, and the presence of major pharmaceutical and biotech companies. Additionally, strong support from government initiatives and a high demand for biopharmaceuticals contribute to North America’s leading position in this market. On the other hand, the Asia-Pacific region is the fastest-growing market for recombinant chemicals. The rapid growth in this region is fueled by increasing healthcare expenditures, a growing biotech industry, and rising investments in life sciences research. Countries like China and India are at the forefront of this growth due to their expanding pharmaceutical sectors, favorable government policies, and a rising focus on precision medicine. Additionally, the availability of a skilled workforce and the establishment of new biotech startups further accelerate the market expansion in the Asia-Pacific region.

Major market players included in this report are:
Genentech, Inc.
Amgen Inc.
Biogen
Pfizer, Inc.
Novartis AG
Merck & Co.
Sanofi
F. Hoffmann-La Roche AG
Johnson & Johnson Services, Inc.
Bayer AG
Mitsubishi Chemical Group
Bharat Serums and Vaccines (BSV)
Serum Institute of India
University of São Paulo (USP)
Oswaldo Cruz Foundation (FIOCRUZ)

The detailed segments and sub-segment of the market are explained below:
By Product Type:
Recombinant Proteins
Recombinant DNAs
Recombinant Peptides
Others

By Technology:
Microbial Expression Systems
Mammalian Cell Expression Systems
Yeast Expression Systems
Insect Cell Expression Systems
Cell-free Expression Systems

By Application:
Drug Development
Vaccine Production
Therapeutics
Cell Line Development
Agriculture
Food and Beverage
Others

By Region:
North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico
Rest of Latin America

Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2034

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Recombinant Chemicals Market Executive Summary
1.1. Global Recombinant Chemicals Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Technology
1.3.3. By Application
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Recombinant Chemicals Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Recombinant Chemicals Market Dynamics
3.1. Market Drivers
3.1.1. Rise in Demand for Recombinant Protein Vaccines
3.1.2. Surge in Prevalence of Genetic Disorders
3.2. Market Challenges
3.2.1. Economic Uncertainty and Cost Concerns
3.3. Market Opportunities
3.3.1. Innovations in Recombinant DNA Technology
3.3.2. Expansion of Application Areas

Chapter 4. Global Recombinant Chemicals Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Recombinant Chemicals Market Size & Forecasts by Product Type 2022-2032
5.1. Segment Dashboard
5.2. Global Recombinant Chemicals Market: Product Type Revenue Trend Analysis, 2022 & 2032(USD Billion)
5.2.1. Recombinant Proteins
5.2.2. Recombinant DNAs
5.2.3. Recombinant Peptides
5.2.4. Others

Chapter 6. Global Recombinant Chemicals Market Size & Forecasts by Technology 2022-2032
6.1. Segment Dashboard
6.2. Global Recombinant Chemicals Market: Technology Revenue Trend Analysis, 2022 & 2032(USD Billion)
6.2.1. Microbial Expression Systems
6.2.2. Mammalian Cell Expression Systems
6.2.3. Yeast Expression Systems
6.2.4. Insect Cell Expression Systems
6.2.5. Cell-free Expression Systems

Chapter 7. Global Recombinant Chemicals Market Size & Forecasts by Application 2022-2032
7.1. Segment Dashboard
7.2. Global Recombinant Chemicals Market: Application Revenue Trend Analysis, 2022 & 2032(USD Billion)
7.2.1. Drug Development
7.2.2. Vaccine Production
7.2.3. Therapeutics
7.2.4. Cell Line Development
7.2.5. Agriculture
7.2.6. Food and Beverage
7.2.7. Others

Chapter 8. Global Recombinant Chemicals Market Size & Forecasts by Region 2022-2032
8.1. North America Recombinant Chemicals Market
8.1.1. U.S. Recombinant Chemicals Market
8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
8.1.1.2. Technology breakdown size & forecasts, 2022-2032
8.1.1.3. Application breakdown size & forecasts, 2022-2032
8.1.2. Canada Recombinant Chemicals Market
8.2. Europe Recombinant Chemicals Market
8.2.1. UK Recombinant Chemicals Market
8.2.2. Germany Recombinant Chemicals Market
8.2.3. France Recombinant Chemicals Market
8.2.4. Spain Recombinant Chemicals Market
8.2.5. Italy Recombinant Chemicals Market
8.2.6. Rest of Europe Recombinant Chemicals Market
8.3. Asia-Pacific Recombinant Chemicals Market
8.3.1. China Recombinant Chemicals Market
8.3.2. India Recombinant Chemicals Market
8.3.3. Japan Recombinant Chemicals Market
8.3.4. Australia Recombinant Chemicals Market
8.3.5. South Korea Recombinant Chemicals Market
8.3.6. Rest of Asia Pacific Recombinant Chemicals Market
8.4. Latin America Recombinant Chemicals Market
8.4.1. Brazil Recombinant Chemicals Market
8.4.2. Mexico Recombinant Chemicals Market
8.4.3. Rest of Latin America Recombinant Chemicals Market
8.5. Middle East & Africa Recombinant Chemicals Market
8.5.1. Saudi Arabia Recombinant Chemicals Market
8.5.2. South Africa Recombinant Chemicals Market
8.5.3. Rest of Middle East & Africa Recombinant Chemicals Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Genentech, Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Amgen Inc.
9.3.3. Biogen
9.3.4. Pfizer, Inc.
9.3.5. Novartis AG
9.3.6. Merck & Co.
9.3.7. Sanofi
9.3.8. F. Hoffmann-La Roche AG
9.3.9. Johnson & Johnson Services, Inc.
9.3.10. Bayer AG
9.3.11. Mitsubishi Chemical Group
9.3.12. Bharat Serums and Vaccines (BSV)
9.3.12. Serum Institute of India
9.3.14. University of São Paulo (USP)
9.3.15. Oswaldo Cruz Foundation (FIOCRUZ)
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now